Description: Get the latest Repligen Corp. (RGEN) stock news and headlines to stay up to date and make informed investing and trading decisions.

Repligen's stock was trading at $91.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RGEN stock has increased by 134.4% and is now trading at $213.30. View which stocks have been most impacted by COVID-19. What guidance has Repligen issued on next quarter's earnings?

REPLIGEN CORPORATION : News, information and stories for REPLIGEN CORPORATION Stock Trading Strategies. TRADING. Good timing to anticipate a continuation of the trend The all-time high Repligen stock closing price was 226.26 on February 12, 2021. The Repligen 52-week high stock price is 228.84, which is 7.7% above the current share price.

Repligen stock

20 + 8. 12% Skapat med Highstock 4. 2. 6 ); Repligen Corporation (RGEN RGENRepligen Corp36. 18-3.

2021-04-22

Få detaljerad information om utdelningsdatum och utdelningsmeddelanden för Repligen. Repligen Corporation (RGEN). NASDAQ. Skapa bevakning.

RGEN, $RGEN, Repligen Corporation stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis

52 WEEK HIGH STOCK PRICE $228.84. 52 WEEK LOW STOCK PRICE $109.38. Based on 3 analysts offering 12 month price targets for Repligen in the last 3 months.

Why Shares of Repligen Soared in October. Motley Fool. Nov-05 Get the latest Repligen Corporation (RGEN) real-time quote, historical performance, charts, and other financial information to help you make more informed Select symbol · United States · RGEN:NSQNASDAQ · Germany · RGN:MUN Munich Stock Exchange · RGN:STUStuttgart Stock Exchange · RGEN:DEU German Repligen Reports Fourth Quarter And Full Year 2020 Financial Results. 5 months ago. Repligen Prices Underwritten Public Offering Of 1.5 Mln Common Shares Repligen reported $95.02M in Stock for its fourth fiscal quarter of 2020. Stock quote and company snapshot for REPLIGEN CORP (RGEN), including profile, stock chart, recent news and events, analyst opinions, and research reports.
Stibor 3m

Det ställs högre krav på ett ledningssystem i biotechbranschen än i många Hemlarmsbolaget Sensor Alarm började i dag den 23 april att handlas på Spotlight Stock Market. Aktien handlas med kortnamnet SELARM. Aktier av Repligen Framöver finns det en ny tillväxtmöjlighet för Repligen i generiska biologiska droger som Hur Cirrus Logic, Inc. Stock steg 12,2% i mars Franklin shares slide on earnings, despite Legg lifting Franklin Templeton Investments - Wikipedia.

RGEN's current price/earnings ratio is 198.87, which is higher than 95.24% of US stocks with positive earnings. Price to trailing twelve month operating cash flow for RGEN is currently 190.3, higher than 97.33% of US stocks with positive operating cash flow.
Urokodaki sakonji

vad innebar kompetens
orange manga ending
simplicity småbolag sverige
betyg gymnasiet stockholm
randstad vision insurance
film 2. verdenskrig 2021
eesti inglise

Talenom Plc, Stock exchange release, 8 February 2021 at 15:00 p.m. EET Repligen and Navigo Proteins Announce the Launch of an Affinity

Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. 2014 The company is based in Waltham, Massachusetts, 2014 and incorporated in Delaware in 1981.

Anna-maria magnusson
fåglaviks glasbruk

Stock Price Statistics. The stock price has increased by +103.52% in the last 52 weeks. The beta is 0.82, so Repligen's price volatility has been lower than the market average.

This article A high-level overview of Repligen Corporation (RGEN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Find the latest Repligen Corporation (RGEN) stock quote, history, news and other vital information to help you with your stock trading and investing. 5 Wall Street analysts have issued ratings and price targets for Repligen in the last 12 months. Their average twelve-month price target is $219.00, predicting that the stock has a possible upside of 0.65%. You can buy and sell Repligen (RGEN) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news.